Kataloge von Arigo Biolaboratories
arigoPLEX® Multiplex ELISAs
The arigoPLEX® Multiplex ELISA kits are ELISA-based immunoassays that allow simultaneous detection of 4 or 8 key cytokines/factors and that can be analysed using a standard ELISA reader. The kits show a high sensitivity at pg/ml ranges and are validated on serum, plasma and cell culture supernatant. Unlike Luminex assays, which are primarily used for broad cytokine screening, arigo’s Multiplex ELISA kits are designed to validate specific physiological effects by quantifying cytokines involved in inflammation and cell therapy-mediated cytotoxicity. Released July 2026.
M13 Phage Display Solutions for Antibody Discovery
M13 phage display is a widely used technology for antibody discovery and screening, enabling the selection of high-affinity binders against specific targets. The technique links antibody binding properties to M13 bacteriophages, allowing efficient identification and optimization of therapeutic antibody candidates. Arigo offers M13 phage-specific antibodies (unconjugated and HRP-conjugated) with high sensitivity and excellent performance in ELISA and FACS applications. In addition, Arigo provides a comprehensive range of anti-human secondary antibodies targeting multiple immunoglobulin classes and subclasses, facilitating antibody screening, characterization, and validation in M13 phage display applications. Released July 2026.
Veterinary Virus and Zoonotic Disease
Veterinary viruses pose a problem in veterinary medicine, as these viral infections affect animals of economic importance. Current research focuses on elucidating the mechanisms of viral transmission, the interactions between host and pathogen, and the clinical consequences of infections in economically important animals. Understanding these processes is crucial for the development of efficient diagnostic methods, effective vaccines and targeted treatment strategies. Arigo offers a range of antibodies and ELISA kits to support research into veterinary viruses. Released July 2026.
Arabidopsis thaliana Research Antibodies
Arabidopsis thaliana is the most widely used model plant in molecular biology and plant science, providing valuable insights into plant development, signaling, metabolism, and stress responses. Research on Arabidopsis requires reliable tools for studying protein expression, localization, and regulation. Arigo offers a growing portfolio of Arabidopsis thaliana antibodies targeting key proteins involved in signaling, photosynthesis, stress responses, and metabolism, including ABF3, ABI2, ABI5, MPK6, RbcL, S6K1 pT449, and many others. Arigo also provides high-quality epitope tag antibodies against HA, Myc, and 6x His tags, facilitating the detection and characterization of recombinant proteins in Arabidopsis studies. Released July 2026.
Inflammation Antibody Panels
Inflammation is a protective immune response to infection, injury, or other harmful stimuli. It involves activation of inflammatory signaling pathways and recruitment of immune cells to restore tissue homeostasis. To support inflammation research, arigo offers the Inflammation Antibody Panel for detecting NF-κB activation, iNOS, and COX-2, the Neuroinflammation Antibody Panel for analyzing microglia and astrocytes, and the Human and Mouse Inflammatory Cell Antibody Panels for identifying neutrophils, macrophages, T cells, and B cells in tissue samples. Released July 2026.
Senescence Research Tools
Senescence is a stable state of cell cycle arrest that occurs in response to stress, DNA damage, or telomere shortening. It is characterized by activation of the p16-Rb and p53-p21 pathways, increased SA-β-Gal activity, and the development of a senescence-associated secretory phenotype (SASP). Arigo offers the Senescence Antibody Panel for studying the p16-Rb and p53-p21 pathways, the SAHF Antibody Duo for detecting senescence-associated heterochromatin foci, and the Cellular Senescence Assay Kit for quantifying SA-β-Gal activity. In addition, arigo provides a range of ELISA kits for measuring key SASP factors. Released July 2026.
Inflammasome & Pyroptosis Antibody Panels
Pyroptosis is an inflammatory form of regulated cell death driven by inflammasome activation, leading to Caspase‑1 activation, gasdermin cleavage, and the release of pro-inflammatory cytokines such as IL‑1β. Key inflammasomes involved in this process include NLRP3 and NLRC4. Arigo offers the Pyroptosis Antibody Panel targeting Caspase‑1, GSDMD, and IL‑1β, the GSDME-mediated Pyroptosis Antibody Panel targeting Caspase‑3, GSDME, and HMGB1, and dedicated NLRP3 and NLRC4 Inflammasome Antibody Panels containing antibodies against the core inflammasome components NLRP3/NLRC4, ASC, and Caspase‑1. These panels are validated for human and mouse samples, with the GSDME panel also supporting rat samples. Released July 2026.
Cuproptosis Antibody Panels
Cuproptosis is a form of regulated cell death caused by excess intracellular copper. It is characterized by the aggregation of lipoylated proteins, loss of Fe-S cluster proteins, and the induction of proteotoxic stress, leading to cell death. To support cuproptosis research, Arigo offers the Proteotoxic Stress Antibody Panel, containing DLAT, DLST, and HSP70 antibodies to monitor proteotoxic stress, and the Fe-S Cluster Antibody Panel, which includes FDX1, LIAS, ACO2, and POLD1 antibodies to evaluate Fe-S cluster loss. Both panels are validated for use with human and mouse samples. Released July 2026.
Ferroptosis Research Tools
Ferroptosis is an iron-dependent form of regulated cell death driven by lipid peroxidation and oxidative membrane damage. It has been implicated in cancer, neurodegeneration, and other diseases, making lipid peroxidation a key marker for ferroptosis research. Arigo offers the Ferroptosis/Oxytosis Antibody Panel, which includes key molecular markers of ferroptosis and oxytosis, as well as markers of lipid peroxidation. In addition, arigo provides antibodies for detecting lipid peroxidation products such as Malondialdehyde (MDA), 4-Hydroxynonenal (4-HNE), and Acrolein. These products are suitable for human, mouse, and rat samples. Released July 2026.
Ripoptosome & Necroptosis Antibody Panels
Ripoptosome and necroptosis are closely related cell death pathways that regulate cellular responses to stress and inflammation. While the ripoptosome promotes apoptosis through RIP1 and Caspase-8, activation of RIP1, RIP3, and MLKL drives necroptosis, a regulated form of inflammatory cell death. Arigo offers the Mouse Ripoptosome Antibody Panel for detecting RIP1, Caspase-8, p-RIP1, and p-RIP3, enabling discrimination between apoptosis and necroptosis. The Necrosome Antibody Panel includes RIP1, RIP3, and MLKL antibodies for convenient detection of necrosome formation and necroptosis. Released July 2026.
Antibody Panels & arigoPLEX® Multiplex ELISAs
The arigoPLEX® product line by Arigo includes antibody panels and Multiplex ELISA kits. The Multiplex ELISAs allow for multiple detection of 4 or 8 key cytokines/factors simultaneously and can be analysed using a standard ELISA reader. Both, the antibody panels and the Multiplex ELISAs, are good for analyzing multiple key proteins in popular research topics such as inflammation, oxidative stress or cancer, making the arigoPLEX® series an all-in-one solution for easy, efficient and economic research. Released September 2024.
Recombinant Rabbit Monoclonal Antibodies
Catalog featuring Recombinant Rabbit Monoclonal Antibodies. These are refered to as SQab clones, which are named after the abbreviation of "Squirrel", the mascot of arigo Biolaboratories Corp. SQab clones are developed by proprietary technologies and validated by extensive processes that allow confidence in specificity, sensitivity, and consistency. Released May 2022.